title: The need for adverse effects reporting standards in oncology clinical trials.
authors.forename: Andy
authors.initials: A
authors.lastname: Trotti
authors.forename: Soren M
authors.initials: SM
authors.lastname: Bentzen
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D023381:Endpoint Determination; D019317:Evidence-Based Medicine; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D007258:Informed Consent; D011878:Radiotherapy / Q000009:adverse effects; D012016:Reference Values; D012307:Risk Factors